The following companies are the first to be selected to become residents of Janssen Labs: CompanyLeadershipTechnologyDiomics
Dr. Jeff Morhet
Dennison Business Leader of the Year Award for his work in innovative entrepreneurialism
Diagnostics, forensics, integrated DNA analysis and genetic solutionsNeurolixis
Dr. Adrian Newman-Tancredi
Chief Scientific Officer
To design and develop novel small molecule compounds against a number of targets in the CNS targeting treatment-resistant depression, cognitive deficits in schizophrenia and symptomatic treatment of Parkinson's disease. Tem Systems
Dr. Robert Hillman
Founder and CEO of Accumetrics, ActivX BioSciences (acquired by Kyorin Inc), Founder Biotrack (acquired by Boehringer Mannheim), Ph.D.
Medical diagnostic systems that provide a comprehensive profile of a patient's coagulation status.Yolia Health
Alberto Osio, CEO and Founder
Yolia's co-founders, Alberto and Eduardo Osio (siblings) have been named by CNN Expansion, Mexico's Top Entrepreneurs of the year in 2007 and 2010
Optometric devices for cost-effective, non-invasive forms of treatment Janssen Research & Development, LLCJanssen Research & Development, LLC, (Janssen), is one of the Janssen Pharmaceutical Companies. Janssen is headquartered in Raritan, N.J., and has facilities in Europe, the United States and Asia. Janssen is leveraging drug discovery and drug development in a variety of therapeutic areas, including Neuroscience, Oncology, Immunology, Infectious Diseases, and Cardiovascular and Metabolism to address unmet medical needs worldwide.More information can be found at
|SOURCE Janssen Research & Development, LLC|
Copyright©2010 PR Newswire.
All rights reserved